# TGRX-326 Pharmacokinetic Food Effect Bioavailability Study

> **NCT06304805** · PHASE1 · COMPLETED · sponsor: **Shenzhen TargetRx Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** cycle 1: treatment drug
- **DRUG:** cycle 1: reference drug
- **BEHAVIORAL:** cycle 1: fasted
- **BEHAVIORAL:** cycle 1: food
- **DRUG:** cycle 2: treatment drug
- **DRUG:** cycle 2: reference drug
- **BEHAVIORAL:** cycle 2: fasted
- **BEHAVIORAL:** cycle 2: food
- **DRUG:** cycle 3: treatment drug
- **DRUG:** cycle 3: reference drug
- **BEHAVIORAL:** cycle 3: fasted
- **BEHAVIORAL:** cycle 3: food

## Key facts

- **NCT ID:** NCT06304805
- **Lead sponsor:** Shenzhen TargetRx Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-13
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-01-19
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304805, "TGRX-326 Pharmacokinetic Food Effect Bioavailability Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06304805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*